L2 Asset Management, LLC Bristol Myers Squibb CO Transaction History
L2 Asset Management, LLC
- $492 Million
- Q1 2025
A detailed history of L2 Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, L2 Asset Management, LLC holds 20,400 shares of BMY stock, worth $995,316. This represents 0.25% of its overall portfolio holdings.
Number of Shares
20,400
Previous 18,443
10.61%
Holding current value
$995,316
Previous $1.04 Million
19.27%
% of portfolio
0.25%
Previous 0.2%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.34 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.74 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.27 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.63 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.24 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...